Amalgamated Bank Innoviva, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Innoviva, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 16,402 shares of INVA stock, worth $314,098. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,402

Previous 16,857 2.7%

Holding current value

$314,098

Previous $276,000 14.86%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$16.33 - $20.04 $7,430 - $9,118	-455 Reduced 2.7%	16,402 $317,000
Q2 2024 Aug 12, 2024	SELL	$14.4 - $16.4 $20,678 - $23,550	-1,436 Reduced 7.85%	16,857 $276,000
Q1 2024 Apr 23, 2024	SELL	$14.56 - $16.78 $38,351 - $44,198	-2,634 Reduced 12.59%	18,293 $279,000
Q4 2023 Feb 06, 2024	SELL	$12.32 - $16.27 $27,424 - $36,217	-2,226 Reduced 9.61%	20,927 $336,000
Q3 2023 Nov 08, 2023	SELL	$12.37 - $13.89 $15,462 - $17,362	-1,250 Reduced 5.12%	23,153 $301,000
Q2 2023 Aug 11, 2023	SELL	$11.39 - $13.72 $47,701 - $57,459	-4,188 Reduced 14.65%	24,403 $310,000
Q1 2023 May 02, 2023	SELL	$10.73 - $13.6 $20,762 - $26,316	-1,935 Reduced 6.34%	28,591 $322,000
Q3 2022 Nov 09, 2022	BUY	$11.61 - $15.22 $3,239 - $4,246	279 Added 0.92%	30,526 $354,000
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $60,487 - $83,973	4,224 Added 16.23%	30,247 $446,000
Q1 2022 Jun 30, 2022	SELL	$15.39 - $20.25 $20,791 - $27,357	-1,351 Reduced 4.94%	26,023 $504,000
Q4 2021 Feb 15, 2022	SELL	$15.91 - $18.72 $20,555 - $24,186	-1,292 Reduced 4.51%	27,374 $472,000
Q3 2021 Oct 29, 2021	SELL	$13.06 - $17.24 $36,633 - $48,358	-2,805 Reduced 8.91%	28,666 $479,000
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $360,342 - $439,335	31,471 New	31,471 $422,000
Q1 2021 May 13, 2021	SELL	$11.06 - $12.87 $115,776 - $134,723	-10,468 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$9.33 - $12.48 $634 - $848	68 Added 0.65%	10,468 $129,000
Q3 2020 Oct 30, 2020	SELL	$10.33 - $14.49 $3,470 - $4,868	-336 Reduced 3.13%	10,400 $109,000
Q2 2020 Aug 10, 2020	SELL	$11.49 - $15.26 $13,948 - $18,525	-1,214 Reduced 10.16%	10,736 $150,000
Q1 2020 May 13, 2020	SELL	$8.11 - $15.23 $3,698 - $6,944	-456 Reduced 3.68%	11,950 $141,000
Q4 2019 Feb 13, 2020	BUY	$10.28 - $14.38 $4,862 - $6,801	473 Added 3.96%	12,406 $176,000
Q3 2019 Nov 13, 2019	SELL	$10.05 - $14.55 $1,165 - $1,687	-116 Reduced 0.96%	11,933 $126,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $7,414 - $8,461	566 Added 4.93%	12,049 $175,000
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $4,873 - $7,141	356 Added 3.2%	11,483 $161,000
Q4 2018 Feb 15, 2019	BUY	$13.96 - $18.26 $155,332 - $203,179	11,127 New	11,127 $194,000
Q3 2018 Nov 14, 2018	SELL	$13.63 - $15.7 $153,569 - $176,891	-11,267 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$13.44 - $17.59 $6,840 - $8,953	509 Added 4.73%	11,267 $155,000
Q1 2018 May 22, 2018	SELL	$13.8 - $16.99 $2,001 - $2,463	-145 Reduced 1.33%	10,758 $179,000
Q4 2017 Feb 13, 2018	BUY	$11.73 - $14.75 $6,087 - $7,655	519 Added 5.0%	10,903 $155,000
Q3 2017 Nov 09, 2017	BUY	$12.06 - $14.12 $125,231 - $146,622	10,384	10,384 $147,000

Others Institutions Holding INVA

# of Institutions

229

Shares Held

79.2M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Innoviva, Inc. Transaction History